- Home
- AUDC vs NYXH Comparison
AUDC vs NYXH Comparison
Compare AUDC & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUDC
- NYXH
- Stock Information
- Founded
- AUDC 1992
- NYXH 2009
- Country
- AUDC Israel
- NYXH Belgium
- Employees
- AUDC N/A
- NYXH N/A
- Industry
- AUDC Telecommunications Equipment
- NYXH Medical/Dental Instruments
- Sector
- AUDC Utilities
- NYXH Health Care
- Exchange
- AUDC Nasdaq
- NYXH Nasdaq
- Market Cap
- AUDC 339.7M
- NYXH 394.1M
- IPO Year
- AUDC 1999
- NYXH 2021
- Fundamental
- Price
- AUDC $11.40
- NYXH $10.35
- Analyst Decision
- AUDC Buy
- NYXH Strong Buy
- Analyst Count
- AUDC 2
- NYXH 5
- Target Price
- AUDC $11.25
- NYXH $17.00
- AVG Volume (30 Days)
- AUDC 124.9K
- NYXH 30.4K
- Earning Date
- AUDC 02-04-2025
- NYXH 03-13-2025
- Dividend Yield
- AUDC 1.56%
- NYXH N/A
- EPS Growth
- AUDC 78.82
- NYXH N/A
- EPS
- AUDC 0.50
- NYXH N/A
- Revenue
- AUDC $242,176,000.00
- NYXH $5,668,079.00
- Revenue This Year
- AUDC $5.02
- NYXH $22.93
- Revenue Next Year
- AUDC $4.31
- NYXH $411.04
- P/E Ratio
- AUDC $23.14
- NYXH N/A
- Revenue Growth
- AUDC N/A
- NYXH 32.65
- 52 Week Low
- AUDC $7.70
- NYXH $6.76
- 52 Week High
- AUDC $14.04
- NYXH $20.00
- Technical
- Relative Strength Index (RSI)
- AUDC 54.19
- NYXH 51.74
- Support Level
- AUDC $11.01
- NYXH $10.47
- Resistance Level
- AUDC $12.72
- NYXH $10.92
- Average True Range (ATR)
- AUDC 0.52
- NYXH 0.41
- MACD
- AUDC -0.07
- NYXH -0.11
- Stochastic Oscillator
- AUDC 52.86
- NYXH 4.61
About AUDC AudioCodes Ltd.
AudioCodes Ltd develops and sells advanced and converged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.
About NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.